CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
Universitätsklinikum Hamburg-Eppendorf
1,000 participants
Nov 1, 2020
OBSERVATIONAL
Conditions
Summary
This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice. Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.
Eligibility
Inclusion Criteria4
- clinically significant mitral insufficiency
- patient underwent screening for TMVI
- echocardiography data at baseline (and after TMVI, E2E and surgery)
- follow-up of at least 30 days
Exclusion Criteria1
- \- age under 18 years
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(43)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04688190